About Charles River Laboratories
Charles River Laboratories is a publicly listed company based in Wilmington (United States) founded in 1947. Provider of drug discovery and preclinical development services. The company has 20,100 employees. Charles River Laboratories has completed 29 acquisitions, including Accugenix, Agilux Laboratories and Argenta Discovery. Its website criver.com draws about 225 thousand monthly visits. Its Indian entity Charles River Laboratories India Private Limited reported revenue of ₹99.82 Cr. Charles River Laboratories offers products and services including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its competitors include Cytel, LabCorp and Precision Medicine Group; 2 of its 3 listed competitors have raised funding.
Company details
Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNSpain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of 2.9 B and a net profit of 364.3 M.
- Headquarters Wilmington, United States
- Employees 20,100
- Stage Public
- SectorsHealthcare
- Website criver.com
- Social LinkedIn Instagram
- Legal Name Charles River Laboratories International, Inc.
Associated legal entities of Charles River Laboratories
Charles River Laboratories operates through Charles River Laboratories India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Charles River Laboratories India Private Limited CIN U24119KA2008PTC047975 | Active | 08 Oct 2008 | Bangalore, Karnataka | ₹99.8 Cr | 52 | 6 | View details |
Products & Services of Charles River Laboratories
Charles River Laboratories offers a comprehensive portfolio of products and services, including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing.
Supplies animal models for basic research and testing purposes.
Accelerates discovery through comprehensive target and lead optimization services.
Offers tailored solutions for antibody therapeutic development and IND support.
Provides testing for biologics from discovery to commercialization stages.
Funding Insights of Charles River Laboratories
- Total Rounds 10
- Last Round Grant — $1.3M
- First Round $150,391
(Mar 2004)
- Investors Count 5
All 10 funding rounds of Charles River Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $1.3M | Grant | – | – | |
| Jun 2021 | $9,181 | Grant | – | – | |
| Oct 2019 | $239,600 | Grant | – | – | |
| Jan 2019 | $338,600 | Grant | – | – | |
| Nov 2015 | $118,814 | Grant | – | – | |
| Sep 2011 | $34M | Grant | – | – | |
| Sep 2010 | $150,391 | Grant | – | – | |
| Jul 2010 | $1.33M | Grant | – | – | |
| Jul 2010 | $149,275 | Grant | – | – | |
| Mar 2004 | $150,391 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Charles River Laboratories
Charles River Laboratories has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States | ||
| foundationforchemistry.org |
Investor details for Charles River Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Charles River Laboratories India Private Limited (Charles River Laboratories)
Charles River Laboratories India Private Limited is the primary company behind Charles River Laboratories. The board of Charles River Laboratories India Private Limited currently have 5 directors; the longest-serving is Prafulla Krishnaji Chitnis, appointed in 2009. 19 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prafulla Krishnaji Chitnis DIN 02476050 | Managing Director | 02 Jan 2009 | 17 yrs 10 mo | Charles River Laboratories India Private Limited |
| Kevin John Finn DIN 09706567 | Director | 25 Aug 2022 | 4 yrs 2 mo | Charles River Laboratories India Private Limited |
| Jon Galli DIN 09799394 | Director | 13 Dec 2022 | 3 yrs 10 mo | Charles River Laboratories India Private Limited |
| Amro Elabbas DIN 11149457 | Additional Director | 11 Jun 2025 | 1 yr 5 mo | Charles River Laboratories India Private Limited |
| Rajesh Puthiya Sudhakaran DIN 11463270 | Managing Director | 12 Jan 2026 | 9 mo | Charles River Laboratories India Private Limited |
People of Charles River Laboratories
387 people are tracked at Charles River Laboratories (170 in leadership, 217 in team); the tracked headcount is 20,100.
| Name | Role | Group |
|---|---|---|
Getachew Sequar | Sr Director Business Development | Leadership |
Kerry Colligan | Senior Director, Digital And Growth Marketing | Leadership |
Jeff Simons | Director Of Digital Customer Experience | Leadership |
Krystina Feucht | Director Of Marketing, Global Research Models And Services | Leadership |
Monica Lombardo | Vice President, Global Total Rewards | Leadership |
Debiparna Chakraborty | Director Of Marketing, Biologics And CDMO Solutions | Leadership |
David P. Johst | Corporate EVP, General Counsel & Chief Administrative Officer | Leadership |
Shweta Singh Upadhyay | Senior Director, Business Development | Leadership |
Jon Pidanick | Business Development Director Insourcing Solutions | Leadership |
Katlyn Ratzlaff | Talent Acquisition Partner | Leadership |
Beth Tebeau | Site Director | Leadership |
Andria Riti | Associate Director, Strategic Communications And Marketing | Leadership |
Michael Hakeem | Senior Director Global Talent Acquisition | Leadership |
Jan Stallen | Associate Director Biotherapeutics Drug Discovery | Leadership |
Bindhu Verghese | Associate Director, Microbial Databases And Genomics | Leadership |
Birgit Girshick | Corporate EVP & COO | Leadership |
Gina Mullane | Corporate SVP & CMO | Leadership |
James C. Foster | Chairman, President & CEO | Leadership |
Victoria L. Creamer | Corporate SVP & Chief People Officer | Leadership |
William D. Barbo | Corporate EVP & Chief Commercial Officer | Leadership |
367 more people are available in the full profile.
Complete people profiles for Charles River Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Charles River Laboratories
Charles River Laboratories is a publicly listed company on the NYSE with ticker symbol CRL in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Jun 2000
- Listed onNYSE: CRL
- Listed entityCharles River Laboratories International, Inc.
- Exchange sectorCommercial services
- ISINUS1598641074
- Share price$299.02 (-0.94% on the day) · 2026-10-13
- Market capitalisation$14.27B
- EPS (diluted, trailing year)$-4.85
- Volume (last session)753,331
Financials of Charles River Laboratories
Figures of Charles River Laboratories India Private Limited, the primary company behind Charles River Laboratories, for FY 2025. Revenue was ₹99.82 Cr (+15% year on year). Net profit was ₹5.35 Cr (5% margin). EBITDA was ₹7.95 Cr (8% margin). Revenue has grown at a compounded annual rate of +12% over three years and +10% over five years.
- ₹99.82 CrRevenue · FY 2025 · +15% YoY
- ₹5.35 CrNet profit · 5% margin
- ₹7.95 CrEBITDA · 8% margin
- ₹28.79 CrPaid-up capital
- 52Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $4.02B | -$144.3M | $919.1M |
| 2024 | $4.05B | $10.3M | $928.6M |
| 2023 | $4.13B | $474.6M | $975.3M |
| 2022 | $3.98B | $486.2M | $956.5M |
| 2021 | $3.54B | $391.0M | $868.0M |
Balance sheet, profit and loss, cash flow and ratios of Charles River Laboratories India Private Limited are on its company page.
Detailed financial statements for Charles River Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Charles River Laboratories
Charles River Laboratories has strategically engaged in corporate development activities, having acquired 29 companies. Notable acquisitions include Accugenix, Agilux Laboratories and Argenta Discovery.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Next-generation sequencing is provided for microbiology testing applications. | pathoquest.com | Paris, France | 2010 | Jan 2026 | •••• | |
High-throughput MALDI-TOF platform is utilized for screening services. | samditech.com | Chicago, United States | 2011 | Jan 2023 | $50M | |
Discovery pharmacology and vivarium services are provided to biotech clients. | explorabiolabs.com | San Diego, United States | 2004 | Apr 2022 | •••• | |
Research reagents for drug discovery and functional genomics are developed. | vigenebio.com | Rockville, United States | 2012 | May 2021 | $292.5M | |
Developing specialist cell microarray technology for membrane target deconvolution and receptor identification | retrogenix.com | Whaley Bridge, United Kingdom | 2008 | Mar 2021 | $48.12M | |
Development and manufacturing services for cell-based therapies are provided. | cognatebioservices.com | Hanover, United States | 2002 | Feb 2021 | $875M | |
Next-generation antibody libraries and vaccines are developed. | distributedbio.com | San Francisco, United States | 2010 | Dec 2020 | $83M | |
Biomaterials and immune cell products are developed for health applications. | cellero.com | Lowell, United States | 2004 | Aug 2020 | $38M | |
Provider of biological blood products and services. | hemacare.com | Los Angeles, United States | 1978 | Dec 2019 | $380M | |
In vivo and in vitro toxicology services are provided globally. | citoxlab.com | Evreux, France | 1969 | Feb 2019 | $506.09M |
Complete acquisition details for Charles River Laboratories
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Charles River Laboratories
14 dated milestones of Charles River Laboratories across 79 years, from founding to its latest funding, stage changes and deals.
- Founded Charles River Laboratories is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $150K.
- Acquisition Acquires CiToxLAB.
- Acquisition Acquires HemaCare Corporation.
- Acquisition Acquires Cellero.
- Acquisition Acquires Distributed Bio.
- Acquisition Acquires Cognate Bioservices.
- Acquisition Acquires Retrogenix.
- Acquisition Acquires Vigene Biosciences.
- Acquisition Acquires Explora BioLabs.
- Acquisition Acquires SAMDI Tech.
- Funding Latest funding round, Grant, of $1.3M.
- Acquisition Acquires PathoQuest.
Competitors of Charles River Laboratories
Charles River Laboratories has 3 listed competitors in our database, 2 of them funded. They include Cytel, LabCorp and Precision Medicine Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians | ||
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences |
Detailed competitors of Charles River Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Charles River Laboratories
The website of Charles River Laboratories (criver.com) receives about 224.6K visits a month.
- Monthly visits224.6K
▲ 14.1% vs previous month
Websites whose visitors overlap most with Charles River Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jax.org | 100% | 474.6K | #112,332 | View details | |
| taconic.com | 80% | 49.8K | #707,498 | View details | |
harlan.com | harlan.com | 77% | – | ||
| cell.com | 62% | 5M | #14,619 | View details | |
| evotec.com | 58% | 91K | #396,653 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Charles River Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Charles River Laboratories (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Charles River Laboratories
Complete news archive for Charles River Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charles River Laboratories
Charles River Laboratories was founded in 1947 and raised its 1st funding round 57 years after it was founded.
Charles River Laboratories is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Charles River Laboratories has 20,100 employees.
The primary company behind Charles River Laboratories, Charles River Laboratories India Private Limited, reported revenue of ₹99.82 Cr for FY 2025, up 15% year on year.
Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNSpain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of 2.9 B and a net profit of 364.3 M.
Charles River Laboratories's top competitors include LabCorp, Cytel and Precision Medicine Group.
Charles River Laboratories offers Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing.
Yes, Charles River Laboratories is publicly traded on NYSE under the ticker symbol CRL.
Charles River Laboratories has made 29 acquisitions, including Accugenix, Agilux Laboratories, and Argenta Discovery.
Charles River Laboratories has 5 investors. Key investors include NIH, HHS, European Union, Foundation for Chemistry Research & Initiatives, and OSTI.GOV.
Charles River Laboratories operates through Charles River Laboratories India Private Limited.
The legal entities of Charles River Laboratories currently have 6 directors, including Prafulla Krishnaji Chitnis, Kevin John Finn, Jon Galli and others.